Overview
Nicholas Cross practices practicing medicine in Southampton, United Kingdom.
Mr. Cross is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Philadelphia-Negative Chronic Myeloid Leukemia, Chronic Myelogenous Leukemia (CML), Systemic Mastocytosis, and Mast Cell Activation Syndrome (MCAS).
He is actively involved in clinical research, co-authoring 127 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Nicholas P. Cross
Is Nicholas P. Cross a top-rated expert for Philadelphia-Negative Chronic Myeloid Leukemia?
MediFind is an objective health platform that identifies experts based on real-world data. Nicholas P. Cross is classified as an Distinguished expert for Philadelphia-Negative Chronic Myeloid Leukemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Nicholas P. Cross participate in research or clinical trials?
Yes. Nicholas P. Cross has published 127 articles and abstracts on conditions like Philadelphia-Negative Chronic Myeloid Leukemia. You can view a list of Nicholas P. Cross's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Chronic Myelogenous Leukemia (CML)Mr. Cross isDistinguished. Learn about Chronic Myelogenous Leukemia (CML).
- Mast Cell Activation Syndrome (MCAS)Mr. Cross isDistinguished. Learn about Mast Cell Activation Syndrome (MCAS).
- Philadelphia-Negative Chronic Myeloid Leukemia
- Systemic MastocytosisMr. Cross isDistinguished. Learn about Systemic Mastocytosis.
- Advanced
- Chronic Myelomonocytic Leukemia (CMML)
- Essential ThrombocythemiaMr. Cross isAdvanced. Learn about Essential Thrombocythemia.
- Hypereosinophilic SyndromeMr. Cross isAdvanced. Learn about Hypereosinophilic Syndrome.
- LeukemiaMr. Cross isAdvanced. Learn about Leukemia.
- Myelodysplastic Syndrome (MDS)Mr. Cross isAdvanced. Learn about Myelodysplastic Syndrome (MDS).
- MyelofibrosisMr. Cross isAdvanced. Learn about Myelofibrosis.
- Myeloproliferative Neoplasms (MPN)
- Polycythemia VeraMr. Cross isAdvanced. Learn about Polycythemia Vera.
- Experienced
- Acromicric DysplasiaMr. Cross isExperienced. Learn about Acromicric Dysplasia.
- Acute Myeloid Leukemia (AML)Mr. Cross isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Blood ClotsMr. Cross isExperienced. Learn about Blood Clots.
- MosaicismMr. Cross isExperienced. Learn about Mosaicism.
- SplenomegalyMr. Cross isExperienced. Learn about Splenomegaly.